南洋行家论股
热门股:云升控股上挑RM7.18
云升控股（YINSON，7293，主板能源股）的日线股价趋势，于10月17日显现着一段技术反弹走势，闭市时报7.08令吉，按日涨9仙或1.29%。短期间该股或会上挑7.09-7.18令吉的阻力关口。
17/10/19行情
闭市：7.08令吉
起落：+9仙
成交量：51,194宗
最高：7.11令吉
最低：7.03令吉
本益比：33.038倍
毛周息率：0.847%
52周最高：7.31令吉
52周最低：4.03令吉
http://www.enanyang.my/news/20191018/热门股云升控股上挑rm7-18/
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
Market Buzz
2025-01-15
YINSON2025-01-14
YINSON2025-01-14
YINSON2025-01-14
YINSON2025-01-14
YINSON2025-01-14
YINSON2025-01-13
YINSON2025-01-13
YINSON2025-01-13
YINSON2025-01-13
YINSON2025-01-10
YINSON2025-01-10
YINSON2025-01-10
YINSON2025-01-10
YINSON2025-01-10
YINSON2025-01-10
YINSON2025-01-10
YINSON2025-01-10
YINSON2025-01-10
YINSON2025-01-10
YINSON2025-01-10
YINSON2025-01-09
YINSON2025-01-09
YINSON2025-01-09
YINSON2025-01-09
YINSON2025-01-09
YINSON2025-01-09
YINSON2025-01-08
YINSON2025-01-08
YINSON2025-01-08
YINSON2025-01-08
YINSON2025-01-08
YINSON2025-01-07
YINSON2025-01-07
YINSON2025-01-07
YINSON2025-01-06
YINSON2025-01-06
YINSON2025-01-06
YINSONMore articles on 南洋行家论股
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
2
Good Articles to Share
Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing (Correct)
3
Good Articles to Share
Evercore ISI's Julian Emanuel says its too early to buy weakness
4
Good Articles to Share
5
Good Articles to Share
6
Good Articles to Share
7
Good Articles to Share
Tens of thousands demonstrate in nationwide strike in Belgium | REUTERS
8
Good Articles to Share
Thousands help at huge Los Angeles wildfire donation center | REUTERS
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
